Eligix CD8-HDM System: Physician study

In a U.S. trial, 2 of 9 patients with leukemia or lymphoma given CD8 depleted PBSC using the Eligix CD8-HDM System had GvHD. No relapses or deaths have been seen with short-follow-up. Data were presen...